Mimedx (MDXG) Depreciation & Amortization (CF) (2011 - 2026)

Mimedx has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $528000.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $528000.0, down 5.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (down 1.33% YoY), and the FY2025 annual result was $14.9 million, up 146.33% from the prior year.
• Depreciation & Amortization (CF) came in at $528000.0 for Q1 2026 at Mimedx, down from $572000.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $860000.0 in Q1 2022 to a low of $528000.0 in Q1 2026.
• The 5-year median for Depreciation & Amortization (CF) is $580000.0 (2024), against an average of $650470.6.
• Across the five-year window, Depreciation & Amortization (CF) slumped 34.3% in 2022 and increased 1.42% in 2025, its largest moves.
• Mimedx's Depreciation & Amortization (CF) stood at $796000.0 in 2022, then dropped by 23.24% to $611000.0 in 2023, then retreated by 7.69% to $564000.0 in 2024, then climbed by 1.42% to $572000.0 in 2025, then retreated by 7.69% to $528000.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $528000.0 (Q1 2026), $572000.0 (Q4 2025), and $572000.0 (Q3 2025), per Business Quant data.